Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
SRX Global Inc.
SRX Global Inc. has entered into a stock purchase agreement to acquire CERo Therapeutics from CERo Therapeutics Holdings. The consideration includes the issuance of $1 million in common stock, the discharge of $8.25 million in existing promissory note debt, and the assumption of approximately $1.56 million in liabilities. A 30-day 'go-shop' period has been established to allow for the solicitation of superior acquisition proposals.…more
SRX Global Inc.
SRX Global announced a $1.5 million commitment to launch a new family of AI-powered actively managed ETFs through its EMJX platform in partnership with Kupa Inc. The company expects the first ETF to be available in the first quarter of 2027 and intends to distribute its holdings from the ETF launch to shareholders as a dividend.…more
SRX Global Inc.
SRX Global Inc. has secured consent from required holders to implement a stock repurchase plan, allowing the company to buy back up to $20 million worth of common stock through July 7, 2027. Under this agreement, the company is authorized to repurchase the lesser of 10 million shares or 50% of its issued and outstanding common stock, while amending certain restrictive covenants from its previous securities purchase agreement.…more
26 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
SRX Global Partners with 5T Trading to Launch Multi-Strategy Trading Platform…more
SRX Global is investing $2.5 million to launch a multi-strategy trading platform in partnership with 5T Trading, powered by its EMJX technology. The initiative aims to provide infrastructure and capital to cultivate the next generation of proprietary traders.…more
●●●●●●●● ●●●●● ●●●●●●
SRX Global has entered into a definitive agreement to acquire CERo Therapeutics, a company developing engineered T cell therapies for hematologic malignancies. The transaction aims to accelerate CERo's clinical development programs and enhance its access to capital.…more
●●●●●●●● ●●●●● ●●●●●●
SRX Global has entered into a stock purchase agreement to acquire all outstanding shares of Cero Therapeutics. This transaction marks a full acquisition of the company by SRX Global.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.